热门资讯> 正文

Biodexa Pharmaceuticals GAAP每股收益为-£0.0002

2025-09-12 20:43

Biodexa Pharmaceuticals press release (NASDAQ:BDRX): 1H GAAP EPS of -£0.0002.
Net cash used in operating activities (after changes in working capital) in 1H25 was £3.30 million (1H24: £4.81 million).
The company’s cash balance at June 30, 2025 was £4.04 million.

More on Biodexa Pharmaceuticals

Seeking Alpha’s Quant Rating on Biodexa Pharmaceuticals
Historical earnings data for Biodexa Pharmaceuticals
Financial information for Biodexa Pharmaceuticals

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。